MAPT and dementia: In contrast, both pTau217 and GFAP saw a significant decrease in the percentage of saved tau-PET scans when requiring 90% or 95% sensitivity and looking at the all-cause dementia group alone in BioFINDER-2, with a similar trend observed for pTau217 in TRIAD.